Call for Abstract
8th Global Experts Meeting on Neuro Psychopharmacology 2018, will be organized around the theme “Major Challenges and Breakthroughs in Neuro Psychopharmacology”
Neuro Psychopharmacology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neuro Psychopharmacology 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Neuropsychopharmacology is a multidisciplinary science that is a combination of both psychopharmacology (how drugs affect the mind) and neuroscience. It is the study of neural mechanism by which drugs act upon to influence behavior. It involves mechanisms of neuropathology, pharmacodynamics, psychiatric disorders, and states of consciousness. One of the ultimate aims is to design and develop prescriptions of treatment for a wide range of neuropathological conditions and psychiatric illness. The studies of psychotic disorders, anxiety disorders, degenerative disorders, affective disorders, eating behavior and sleep behavior may directly be influenced by the advancements in neuropsychopharmacology.
Neurotherapeutics are the drugs used for the treatment of psychological, psychiatric, and nervous disorders. In recent years there has been rapid progress in advancing new treatments for neurologic and psychiatric disorders. New therapeutics have emerged for the treatment of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, schizophrenia, bipolar illness, depression, and drug abuse disorders. Progress in neurotherapeutics has occurred in concert with progress in basic science methodologies, neuroimaging, clinical trial design, and trial analysis. The objective of neurotherapeutic drug discovery and development is to identify new treatments that will improve the quality of life (QOL) of patients suffering from neurologic and psychiatric illness
- Track 2-1Current and Future Therapies
- Track 2-2Delivery of Neurotherapeutics
- Track 2-3Stem Cells as neurotherapeutics
- Track 2-4Drugs for neurological disorders
Drug delivery is the method or process by which a target therapeutic agent is released in human to agents to achieve therapeutic effects. This results in increased efficacy and reduced adverse symptoms. There are three broad categories: noninvasive, invasive, and miscellaneous techniques. Even though many substances have therapeutic effect on central nervous system (CNS) diseases, few of the agents have been clinically used because of the presence of a variety of formidable obstacles in the brain that impede drug delivery. This is attributes to the existence of blood brain barrier, which only permits some molecules to pass through the brain freely. In response to this, aggressive research efforts have focused on the development of new methodologies to deliver the drug molecules effectively to the brain.
- Track 3-1Benefits and Risks of Psychiatric Medications During Pregnancy
- Track 3-2Methods of drug delivery
- Track 3-3Barriers to CNS drug delivery
- Track 3-4Drug Delivery Carriers
- Track 3-5Strategies for enhanced CNS drug delivery
- Track 3-6In-vivo and In-vitro models to study drug transport across the barriers
Clinical trials of therapeutics are the experiments or observations that are carried out under standard conditions to learn whether the drugs or therapy work well enough, called "efficacy" or "effectiveness"; and to learn whether they are safe enough, called "safety”. While most clinical trials test one alternative to the novel intervention, some expand to three and may include a placebo. The most common clinical trials investigate the efficacy and safety of new pharmaceutical products, biologics, psychological therapies, or other intervent. Clinical trials are commonly classified into five phases namely I, II, III, IV and V. Each phase is treated as a separate clinical trial. The process of drug-development will normally pass through all the five phases over many years.
Behavioral pharmacology is an interdisciplinary science field referred to as psychopharmacology. It deals with the study of action and effect of psycho-active, mood-altering drugs on behavior (drug-behavior interactions). Using techniques and approaches, it also analyzes how behavioral factors contribute to the use of psychotherapeutics such as anxiolytics, antidepressants, antipsychotics, and narcotics. It studies different drugs and substances ranging from widely-used, legal medications to obscure and illegal recreational drugs. Behavioral pharmacology involves examining all of the factors associated with behavioral illness, instead of just the biomedical aspect, and heals disease by including a component of behavioral change on the part of the patient.
- Track 5-1Sedative, hypnotic, anxiolytic and similar drugs
- Track 5-2Behavioral and pharmacological treatments for substance abuse
- Track 5-3Drug effects on learning or memory.
- Track 5-4Preclinical behavioral pharmacology of a drug
- Track 5-5Drugs and developmental disabilities
Geriatric psychiatry, also called as, psychogeriatrics is a branch of psychology that deals with prevention and treatment of mental illness in elderly people. Psychotropic therapeutic such as anti-depressants are commonly administered to older people to manage behavior and treat mental illness. These drugs are known to have potential adverse side effects on elderly as they are more sensitive to both the therapeutic and toxic effects of the drugs than young people. This necessitates lower doses and longer dosage intervals. It holds true for the treatment of 5 major types of psychiatric illness namely bipolar disorder depression, anxiety, psychotic disorders and dementia. The diagnosis, treatment and management of dementia and depression are two areas of this field. Psychopharmacotherapy must take into account the effects of age-related changes in the structure and function of the brain and various organs.
- Track 6-1Positive Psychiatry, Resilience, and Aging
- Track 6-2palliative care
- Track 6-3Geriatric OCD and treatment
- Track 6-4Hallucinations
Molecular Neuropharmacology is the branch of pharmacology that deals with the study of neuroharmaceuticals in molecular level. The discipline of pharmacology studies the effect of drugs on living beings. Molecular pharmacology uses methods in molecular biology to do this. Molecular biology started t have an impact on neuropharmacology to start the era of molecular neuropharmacology. Molecular targets of drugs acting on CNS were identified and increasing molecular understandings of the receptors has enabled improved drugs design. Molecular imaging plays an important role in neuropharmacology and provides key biomarkers as a bridge from the laboratory to clinical in CNS drug development. Understanding the molecular structure of drugs used for the treatment of neurological disorder is also important.
- Track 7-1Mechanisms of Alcohol Addiction Pathogenesis
- Track 7-2Neurogenesis
- Track 7-3Pharmacogenomics
- Track 7-4Molecular targets of drugs
- Track 7-5Molecular biology in drug development
Cognitive enhancers are therapeutics/drugs that can be used to increase the brain’s function on cognitive measurements such as memory, reasoning, attention, learning and mood. In the scientific community, these cognitive enhancers are also known as smart drugs or as nootropics. The intellectual functions are enhanced by these drugs by affording a high level of neurotransmitters to the brain and triggering important receptors. Use of these cognition-enhancers by healthy individuals in the absence of a medical indication is one of the most controversial topics among, psychiatrists, neuroscientists and physicians. Only a few drugs are known to enhance the aspect of cognition. Stimulants, such as caffeine is the most commonly used class of drug.
- Track 8-1Uses of cognitive enhancers
- Track 8-2Drug effects and behavioral training
- Track 8-3Stimulants and Racetams
- Track 8-4Ups and downs of cognitive enhancers
Pharmacotherapy, as the name suggests, is the process that involves the use of psychotropic drugs for the treatment mental health symptoms and disorders. The study of effects of these drugs is called as pharmacotherapeutics. It comprises knowledge of the sources, chemical properties, biological effects and therapeutic uses of drugs. It is combined with other treatment methods, like physical therapy and diet therapy. Modern pharmacotherapy includes the use of psychotropic, hormonal preparations, chemotherapeutic, and other effective drugs. Some of the pharmaco therapeutics used for treating mental illness includes: Antidepressants, Antipsychotics,Anti-anxiety medications,Mood stabilizers, Stimulants
- Track 9-1Antidepressants
- Track 9-2Mood stabilizers
- Track 9-3Psychotropic medications in the elderly
- Track 9-4Antipsychotics
- Track 9-5Side Effects of Psychotropic Drugs
In the recent years, the underlying mutations for some acquired neurodegenerative diseases have been identified. One continuous sort of change is trinucleotide repeat expansion. It is otherwise called trinucleotide repeat expansion disorder or trinucleotide repeats disorder and is a set of genetic disorder caused by an expansion in the quantity of trinucleotide repeats in specific genes. Each gene influenced by trinucleotide repeat expansion has a different number of repeats those results in sign of sickness. Further understanding of the role of inflammation in the pathogenesis of TREDs may allow for the design of better therapeutic approaches, slowing disease progression and improving the life of patients.
Psychological interventions are actions that are carried out to bring about behavioral changes in people. There are various applications of psychological interventions and the most commonly used in the treatment of mental disorders using psychotherapy. In addition to the attenuation of the symptoms of neural disorder, the intervention is also aimed at identifying the root cause of the disorder. It helps to changing behaviors that prevents violent behavior, promote healthy patterns of diet and exercise, improve children's learning and performance in school, control alcohol abuse, manages the aggressive behavior in children, reduces major depression.
Cognitive science is the interdisciplinary examination of mind and intelligence, psychology, neuroscience, linguistics, philosophy and computational intelligence. This area has a more narrow focus than that of psychotechnology. The first advancement is that cognitive neuroscience is becoming more and more central to all branches of psychology. Advancement in cognitive neuroscience also has important implications for conventional philosophical topics such as the mind-body problem, free will, and even the meaning of life. Cognitive science will continue to progress and that advances in areas such as theoretical neuroscience will provide solution to some of the most challenging questions about the mind. In the past, our knowledge of what is happening in the brain was restricted. Few individuals were examined after death. Now there is a wide range of technologies routinely used in many applications. These technologies are also used to study cognitive development in childhood to understand how the brain develops early on.
- Track 12-1Decision-making
- Track 12-2Learning and Memory
- Track 12-3Mirror neurons
- Track 12-4Social cognition
- Track 12-5Computational neuroscience
- Track 12-6Cognitive psychology
- Track 12-7Emotions
Neuropharmacology is a progressive field of pharmacology that is exponentially growing with the understanding of nervous system and its related disorders, therapeutics and treatments. The various area of research included in this field are mechanisms of novel therapeutics, neuro stem cell therapy, gene therapy in neuronal disorders and neural engineering. Major approaches in scientific discovery and understandings can result from the development and use of new methodologies. The significance of these new methods and therapeutic approaches has the potential to have a major impact on basic and clinical research in pharmacology and toxicology as well as on patient care.
It is branch that is concerned with the study of effect of poison on nervous system. Neurotoxins are substances that affect the normal activity of the nervous system and cause damage to nervous tissue. Neurotoxicity can result from exposure to substances used drug therapies, chemotherapy, radiation treatment, and certain drug abuse. Common symptoms can include loss of memory, concentration, mental processing speed, sleep, compulsive behaviors anxiety, depression, fatigue, numbness of the hands and feet and cognitive and behavioral problems and sexual dysfunction. Individuals with certain disorders may be especially vulnerable to neurotoxins.
- Track 14-1Prognosis
- Track 14-2Mechanisms of Neurotoxicity
- Track 14-3Lead exposure
- Track 14-4Neurotransmission associated Toxicity
Neurocognitive disorders are a group of conditions that usually lead to an impaired mental function. The conditions associated with these disorders are brain injury caused by trauma, cardiovascular disorders, degenerative disorders, drug and alcohol-related conditions etc. The major degenerative causes of neurocognitive disorder are Alzheimer’s and vascular dementia. Neurodegenerative diseases cause the brain and nerves to deteriorate over time, resulting in a gradual loss of neurological function. Neurocognitive disorders can affect memory, attention, learning, language, perception, and social cognition. The risk of developing neurocognitive disorders partly depends on individual’s lifestyle and daily habits.
- Track 15-1Symptoms
- Track 15-2Epidemiology
- Track 15-3Risk of Developing Huntington Disease
- Track 15-4Cognitive Difficulties during Migraine
- Track 15-5Effect of Antihypertensive on Cognitive functions
Alzheimer’s disease is a neurological disorder that is progressive and irreversible, destroying the memory and other important mental functions. It is a chronic disease that usually starts slowly and gets worse over time resulting in inability to carry out simple tasks. The main features of this Alzheimer’s disease are the plaques and tangles formed in the brain. Another feature is the loss of connections between neurons in the brain. The most common early symptom is short-term memory loss and as it advances, symptoms can include problems with language, mood swings, and behavioral issues. The progress in the disease results in loss of the bodily functions and ultimately leads to death.
- Track 16-1Prodromal Symptoms
- Track 16-2Epidemiology of Alzeimer
- Track 16-3Advances in Alzeimer Tests
- Track 16-4Alcohol Consumption and Alzheimer Disease
- Track 16-5Advanced Alzeimer Treatment
Dementia is a syndrome that results in loss of memory and other mental abilities severe enough to interfere with daily life. Many diseases can cause dementia, including Alzheimer's disease, vascular dementia, Parkinson’s disease, and Huntington’s disease. It is caused by physical changes that are caused in the brain. Dementia is usually observed in people over the age of 65. Symptoms may include memory loss and difficulties with thinking, apathetic or uninterested in usual activities, severe enough to reduce a person's ability to perform everyday activities. The symptoms will gradually get worse as more brain cells become damaged and eventually die. It is noticed that more than one type of dementia may exist in the same person.
- Track 17-1The DSM-5’s -New Term for Dementia
- Track 17-2Medication for dementia
- Track 17-3Risk and prevention
- Track 17-4Normal ageing versus dementia
- Track 17-5Stroke-Related Dementia
Parkinson's disease is a disorder of the nervous system that affects the motor functions. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand and also cause stiffness or slowing of movement. Parkinson's disease symptoms and signs may vary from person to person. Symptoms of this kind of disorder include: Tremor, Slowed movement (bradykinesia) Rigid muscles, Impaired posture and balance, Loss of automatic movements and Speech and Writing changes.The disorder is caused when certain nerve cells (neurons) in the brain gradually break down or die. Many of the symptoms are due to a loss of neurons that produce a chemical messenger in the brain called dopamine. When dopamine levels decrease, it causes abnormal brain activity, leading to signs of Parkinson's disease.
- Track 18-1Bradykinesia
- Track 18-2Mechanisms of Disease
Alcohol abuse means having unhealthy or dangerous drinking habits, such as drinking every day or drinking too much at a time. Symptoms includes: Decreased involvement in extracurricular activities, Depression, Lack of interest in family or friends, Restlessness, Inability to control drinking, Erratic behavior and Violent behavior.
The signs and symptoms of alcohol use, as well as the short- and long-term effects of alcohol abuse don't always occur in isolation. In fact, an alarming number of people purposely combine their alcohol with drugs. Drug abuse is a serious public health problem that affects almost every community and family in some way. This is frequently done with the intention of compounding the effects of both to achieve a greater state of intoxication. Some of the drugs used include Methamphetamine, Anabolic steroids, Cocaine, Heroin, Inhalants. Drug abuse also plays a role in many major social problems, such as drugged driving, violence, stress, and child abuse. Most drugs affect the brain's "reward circuit" by flooding it with the chemical messenger dopamine.
- Track 19-1Diagnosing an Addiction
- Track 19-2Effects of Alcohol Abuse
- Track 19-3Mixing Alcohol and Drugs
- Track 19-4Treatment for Addiction
- Track 19-5Teen Alcohol Abuse
A case study is an account of an activity, event or problem that contains a real or hypothetical situation. Case studies can be produced by following a formal research method. These case studies are likely to appear in formal research venues, as journals and professional conferences, rather than popular works. Case studies may involve both qualitative and quantitative research methods.
A scientific report is a document that describes the process, progress, and or results of technical or scientific research or the state of a technical or scientific research problem. It might also include recommendations and conclusion of the research